TAK-063
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for TAK-063, covering 2015-03-20 to 2017-09-29. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia [Phase 2]